Michael A. Incze
Rating: 4.9 of 5
( out of 75 reviews )

Michael A. Incze, MD, MSEd

Languages spoken: English

Clinical Locations

Primary Location

Sugar House Health Center

1280 E. Stringham Avenue
Salt Lake City , UT 84106
801-581-2000
Get Directions

  • Dr. Michael Incze is a primary care physician in the Division of General Internal Medicine who is board certified in internal medicine and addiction medicine. His clinical interests include patient education, high value care, and caring for vulnerable populations including people experiencing homelessness and people with substance use disorders. He regularly volunteers at the Fourth Street Clinic, a federally qualified health center that specialized in providing care to people experiencing homelessness. He is a volunteer physician at the Rosebud Indian Health Service hospital in South Dakota. He also founded a clinic that focuses on providing primary care-based addiction treatment at Sugarhouse Health Center.

    Outside of clinical practice, Dr. Incze is involved in several research, quality improvement, and educational initiatives aimed at improving care for patients with chronic pain and substance use disorders. He serves as a faculty member at the school of medicine and mentors medical students, residents, and fellows. He is also interested in medical writing and has authored numerous commentaries that have appeared in top-tier medical journals. He is the current patient page editor for JAMA Internal Medicine.

    Dr. Incze attended medical school at University of California, Davis and residency at the University of California, San Francisco. In his free time he enjoys cycling, cooking, travelling, and composing music.

    Specialties

    Board Certification

    American Board of Preventive Medicine (Addiction Medicine)
    American Board of Internal Medicine (Internal Medicine)

    Patient Rating

    Rating: 4.9 out of 5
    4.9 /5
    ( out of 75 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. Incze is great.I have referred people to him, with his permission.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. Incze is a wonderful doctor who listens to a patients needs and gives excellent suggestions for treatment and lifestyle. Always very friendly and caring.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    I would recommend Dr. Incze to anyone, he's a great guy as well as a doctor!!!

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Best Dr. I've ever had! And yes, I have referred others to Dr Incze!

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr Incze was very thorough in updating my medical history and recommending other options to better my health.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr Incze has seriously been the best Dr I have ever had or deal with, and I have seen alot of them in my life time. He actually listens and genuinely cares about what I have to say or my input into what I think helps me in my recovery from drugs. I can honestly say he has definitely saved my life and help me get my life back and it's the only Dr's appointment I look forward to

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Good experience.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Dr. Incze is the best Primary Care docs I have ever had. He listens well and I believe he truly cares about his patients. He is what keeps me coming back.

    SUGAR HOUSE HEALTH CENTER
    Rating: 5 out of 5

    Very good Doctor and staff.

  • Dr. Michael Incze is a primary care physician in the Division of General Internal Medicine who is board certified in internal medicine and addiction medicine. His clinical interests include patient education, high value care, and caring for vulnerable populations including people experiencing homelessness and people with substance use disorders. He regularly volunteers at the Fourth Street Clinic, a federally qualified health center that specialized in providing care to people experiencing homelessness. He is a volunteer physician at the Rosebud Indian Health Service hospital in South Dakota. He also founded a clinic that focuses on providing primary care-based addiction treatment at Sugarhouse Health Center.

    Outside of clinical practice, Dr. Incze is involved in several research, quality improvement, and educational initiatives aimed at improving care for patients with chronic pain and substance use disorders. He serves as a faculty member at the school of medicine and mentors medical students, residents, and fellows. He is also interested in medical writing and has authored numerous commentaries that have appeared in top-tier medical journals. He is the current patient page editor for JAMA Internal Medicine.

    Dr. Incze attended medical school at University of California, Davis and residency at the University of California, San Francisco. In his free time he enjoys cycling, cooking, travelling, and composing music.

    Board Certification and Academic Information

    Academic Departments Population Health Sciences -Adjunct Associate Professor
    Psychiatry -Adjunct Associate Professor
    Internal Medicine -Associate Professor
    Academic Divisions General Medicine
    Adult Psychiatry
    Board Certification
    American Board of Preventive Medicine (Addiction Medicine)
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Undergraduate Major: Biology; Minor: Chemistry - University of Utah B.A.
    Graduate Training Pace University M.S.Ed.
    Professional Medical Medicine - University of California, Davis School of Medicine M.D.
    Residency Internal Medicine - University of California, San Francisco Resident

    Selected Publications

    Journal Article

    1. Incze MA, Kelley AT, Singer P (2021). Heterogeneous State Cannabis Policies: Potential Implications for Patients and Health Care Professionals. JAMA, 326(23), 2363-2364. (Read full publication)
    2. Incze M (2021). Reassessing the Role of Routine Urine Drug Screening in Opioid Use Disorder Treatment. JAMA internal medicine, 181(10), 1282-1283. (Read full publication)
    3. Incze M (2021). Should I Get a Coronary CT Scan?. JAMA internal medicine, 181(5), 732. (Read full publication)
    4. Incze M (2021). At the Cusp - Reimagining Infective Endocarditis Care amid the Opioid Epidemic. The New England journal of medicine, 384(4), 297-299. (Read full publication)
    5. Incze MA, Tobey ML, Sequist T (2020). Investing in the Health of American Indians and Alaska Natives. JAMA internal medicine, 180(5), 633-634. (Read full publication)
    6. Incze MA, Kelley AT, Johnson (2022). Reexamining Medicaid Patient Review and Restriction Programs Amid the Evolving Opioid Epidemic. JAMA internal medicine, (Read full publication)
    7. Zhang GY, Incze M (2023). What Should I Know About Hormones for Symptoms of Menopause?. JAMA internal medicine, (Read full publication)
    8. Zhang GY, Incze M (2023). What Should I Know About Stopping Routine Cancer Screening?. JAMA internal medicine, (Read full publication)
    9. Incze MA, Kelley AT, Singer P (2023). Implementing the White House's Strategic Plan to Save Lives Amid the Opioid Crisis: Reaching for the "North Star". JAMA, 329(9), 705-706. (Read full publication)
    10. Incze M (2023). Redesigning Opioid Pain Agreements to Promote Patient-Centered Care. JAMA internal medicine, 183(3), 179-180. (Read full publication)
    11. Parks AL, Incze M (2022). What Can At-home Genetic Tests Tell Me About My Health?. JAMA internal medicine, 182(6), 691. (Read full publication)
    12. Incze MA, Grady D, Inouye S (2023). Announcing Expanded Content for Clinicians Through the Clinical Review and Education Section at JAMA Internal Medicine. JAMA internal medicine, (Read full publication)
    13. Incze MA, Chen D, Galyean P, Kimball ER, Stolebarger L, Zickmund S, Gordon A (2023). Examining the Primary Care Experience of Patients With Opioid Use Disorder: A Qualitative Study. Journal of addiction medicine, 17(4), 401-406. (Read full publication)
    14. Incze MA, Huebler S, Chen D, Stofko A, Wu C, Baylis JD, Wells C, Babbel (2024). Hospitalists' Attitudes and Experiences With Posthospitalization Care Transitions for Patients With Substance Use Disorders: A Cross-sectional Analysis. Journal of addiction medicine, (Read full publication)
    15. Incze MA, Covinsky KE, Inouye S (2024). Introducing the Expanded JAMA Internal Medicine Editorial Fellowship. JAMA internal medicine, 184(3), 241. (Read full publication)
    16. Zhang GY, Incze M (2024). I Am Worried I Have Sciatica-What Do I Need to Know?. JAMA internal medicine, 184(1), 122. (Read full publication)
    17. Incze MA, Azari S, Finnell D (2023). Amplifying the Strength and Leadership of Nurses in Opioid Use Disorder Care-Loud and PROUD. JAMA internal medicine, 183(12), 1354-1356. (Read full publication)
    18. Incze MA, Sehgal SL, Hansen A, Garcia L, Stolebarger (2023). Evaluation of a Primary Care-Based Multidisciplinary Transition Clinic for Patients Newly Initiated on Buprenorphine in the Emergency Department. Substance abuse, 44(3), 220-225. (Read full publication)
    19. Incze MA, Huebler S, Grant S, Gordon A (2024). Using the Delphi Process to Prioritize an Agenda for Care Transition Research for Patients With Substance Use Disorders. Substance use & addiction journal, 45(3), 29767342241246762. (Read full publication)
    20. Incze MA, Slawek D, Cunningham C (2020). What Should I Know About Medical Cannabis?. JAMA internal medicine, 180(4), 624. (Read full publication)
    21. Landefeld J, Incze M (2020). Advance Care Planning-What Should I Know?. JAMA internal medicine, 180(1), 172. (Read full publication)
    22. Incze M (2019). I'm Worried About Depression-What Should I Know?. JAMA internal medicine, 179(11), 1612. (Read full publication)
    23. Incze M (2019). I Have Arthritis of the Knees: What Should I Do?. JAMA internal medicine, 179(5), 736. (Read full publication)
    24. Keshvani N, Gupta A, Incze M (2019). I Am Worried About Gonorrhea: What Do I Need to Know?. JAMA internal medicine, 179(1), 132. (Read full publication)
    25. Kelley AT, Incze MA, Baumgartner M, Campbell ANC, Nunes EV, Scharfstein D (2024). Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders. Drug and alcohol dependence, 261, 111368. (Read full publication)
    26. Incze MA, Stolebarger (2024). On Her Own Two Feet. The New England journal of medicine, 391(2), 105-107. (Read full publication)
    27. Bogler O, Incze M (2024). Endocrine Adverse Effects of Long-Term Opioid Use. JAMA internal medicine, 184(7), 831-832. (Read full publication)
    28. Zhang GY, Incze M (2024). I Am Curious About Cannabis Edibles-What Should I Know?. JAMA internal medicine, (Read full publication)
    29. Incze MA, Huebler S, Szczotka K, Grant S, Kertesz SG, Gordon A (2024). Expert Panel Consensus on the Effectiveness and Implementation of Models to Support Posthospitalization Care Transitions for People With Substance Use Disorders. Journal of addiction medicine, (Read full publication)
    30. Johnson TA, Incze MA, Silverstein W (2024). Heightened Vigilance Needed When Patients Are Prescribed GLP-1 and GIP Agonists. JAMA internal medicine, (Read full publication)
    31. Kneifati-Hayek JZ, Incze M (2024). Reducing Unnecessary Admissions in the Emergency Department. JAMA internal medicine, (Read full publication)
    32. Incze MA, Simon C, Suen L (2024). Methadone's Moment. JAMA, 332(23), 1969-1970. (Read full publication)
    33. Incze MA, Zhang G (2024). Clarifying the Risks of Consuming Edible Cannabis-Reply. JAMA internal medicine, 184(12), 1479-1480. (Read full publication)
    34. Incze MA, Anderson T (2025). Integrating Buprenorphine Into Chronic Pain Treatment-Putting the Choice in VOICE. JAMA internal medicine, (Read full publication)
    35. Kneifati-Hayek JZ, Incze M (2025). What Do I Need to Know About the Pneumococcal Pneumonia Vaccine?. JAMA internal medicine, (Read full publication)
    36. Rostam-Abadi Y, Liebschutz JM, Subramaniam G, Stone R, Appleton N, Mazel S, Alexander K, Brill SB, Case A, Gelberg L, Gordon AJ, Hong H, Incze MA, Kawasaki SS, Kim T, Kline M, Lovejoy TI, McCormack J, Zhang S, McNeely (2025). Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site "Subthreshold Opioid Use Disorder Prevention" (STOP) Trial. Journal of general internal medicine, 40(12), 2906-2915. (Read full publication)
    37. Incze MA, Anderson T, Hansen AM, Szczotka K, Stolebarger L, Tuckett S, Fox S, Bell C, Galyean P, Babbel D, Zickmund (2025). "They Don't Just Need a Handshake or a Handoff, They Need a Hug": A Qualitative Assessment of the Care Transition Experience of Patients with Substance Use Disorders After Hospital Discharge. Journal of general internal medicine, 40(13), 3023-3033. (Read full publication)
    38. Incze MA, Szymczak JE, Done E, Stolebarger L, England N, Marshall E, Raju S, Gray M, Saunders M, Ciarkowski CE, Willey JC, Bristol AA, Amaton U, Vaughn V (2025). Building a Network for Community-Engaged Research Related to Substance Use Disorder Care Transitions: A Commentary With Protocol. Substance use & addiction journal, 47(1), 29767342251358099. (Read full publication)
    39. Incze MA, Huebler S, Baylis JD, Stofko A, Kelley AT, Binswanger IA, Gordon A (2025). Mortality Among Veterans With Opioid Use Disorder After Medical Hospitalization. JAMA internal medicine, 185(6), 734-736. (Read full publication)
    40. Incze MA, Huebler S, Baylis JD, Stofko A, Kelley AT, Binswanger IA, Bart G, Saxon AJ, Manhapra A, Gordon A (2025). Factors associated with mortality following hospitalization among veterans with opioid use disorder. Journal of substance use and addiction treatment, 209797. (Read full publication)
    41. Reeves C, Franks L, Kelley AT, Incze M, Gordon AJ, Yu Z, Flake E, Cochran (2025). Understanding motives for illicit medicinal cannabis use: an exploratory analysis in a medical cannabis program. Journal of cannabis research, 7(1), 48. (Read full publication)
    42. Suen LW, Incze M, Simon C, Englander H, Bratberg J, Groves Scott G, Winograd (2024). Methadone's Resurgence in Bridging the Treatment Gap in the Overdose Crisis: Position Statement of AMERSA, Inc (Association for Multidisciplinary Education, Research, Substance Use, and Addiction). Substance use & addiction journal, 45(3), 337-345. (Read full publication)
    43. Dhruva SS, Tingley SR, Incze M, Neuhaus JM, Bachhuber MA, Redberg R (2025). Evaluation of Payer Policies to Reduce Low-Value Medical Device-Based Procedure Use. JAMA health forum, 6(10), e253898. (Read full publication)
    44. Hill K, Rife-Pennington TL, Zagorski C, Dunham K, Sue KL, Davis C, Incze (2025). In Support of a Public Health Approach to Drug Policy: Position Statement of AMERSA, Inc. Substance use & addiction journal, 29767342251381162. (Read full publication)

    Review

    1. Dickman S, Mirza R, Kandi M, Incze MA, Dodbiba L, Yameen R, Agarwal A, Zhang Y, Kamran R, Couban R, Guyatt G, Hanna (2021). Mortality at For-Profit Versus Not-For-Profit Hemodialysis Centers: A Systematic Review and Meta-analysis. International journal of health services, 51(3), 371-378. (Read full publication)
    2. Kelley AT, Incze MA, Baylis JD, Calder SG, Weiner SJ, Zickmund SL, Jones AL, Vanneman ME, Conroy MB, Gordon AJ, Bridges JF (2022). Patient-centered quality measurement for opioid use disorder: Development of a taxonomy to address gaps in research and practice. Substance abuse, 43(1), 1286-1299. (Read full publication)
    3. Incze MA, Kelley AT, James H, Nolan S, Stofko A, Fordham C, Gordon A (2024). Post-hospitalization Care Transition Strategies for Patients with Substance Use Disorders: A Narrative Review and Taxonomy. Journal of general internal medicine, 39(5), 837-846. (Read full publication)
    4. Franks L, Cochran G, Reeves C, Incze MA, Hardy CJ, Gordon AJ, Kelley A (2024). Evaluations of State Medical Cannabis Programs in the USA: A Narrative Review. Medical cannabis and cannabinoids, 7(1), 243-256. (Read full publication)

    Commentary

    1. Incze M (2021). Necessity of Coronary CT Scans-Reply. JAMA internal medicine, 181(9), 1259. (Read full publication)

    Editorial

    1. Incze MA, Kelley AT, Gordon A (2022). Champions Among Us: Leading Primary Care to the Forefront of Opioid Use Disorder Treatment. Journal of general internal medicine, 37(7), 1771-1773. (Read full publication)
    2. Incze MA, Kelley AT, Gordon A (2021). Improving Opioid Use Disorder Treatment through Quality Assessment. Journal of general internal medicine, 36(9), 2820-2822. (Read full publication)
    3. Incze MA, Parks AL, Stern R (2023). Teaching a Deeper Understanding of the Medical Literature. Journal of general internal medicine, 38(4), 1059-1060. (Read full publication)
    4. Incze MA, Garland E (2023). Mobilizing Primary Care Against the Opioid Crisis in the Post X-Waiver Era. Journal of general internal medicine, 38(16), 3618-3620. (Read full publication)

    Letter

    1. Incze MA, Slawek D, Cunningham C (2020). The Importance of Pediatric Safety in Tetrahydrocannabinol Education-Reply. JAMA internal medicine, 180(7), 1027. (Read full publication)
    2. Kelley AT, Incze M (2023). The need for a more inclusive and objective approach in developing a core outcomes set for opioid use disorder. Addiction (Abingdon, England), 118(1), 194-195. (Read full publication)
    3. Incze MA, Kelley T, Singer P (2023). The White House's Strategic Plan to Address the Opioid Crisis-Reply. JAMA, 329(24), 2195. (Read full publication)

    Other

    1. Warrier G, Incze M (2021). I Want to Lose Weight: Which Diet Is Best?. JAMA internal medicine, 181(9), 1268. (Read full publication)
    2. Incze MA, Kompala (2020). I'm Worried About Low Testosterone-What Should I Know?. JAMA internal medicine, 180(6), 920. (Read full publication)